We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
-1.91%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$151M
AUM Growth
+$10.1M
Cap. Flow
+$16.3M
Cap. Flow %
10.8%
Top 10 Hldgs %
48.77%
Holding
155
New
39
Increased
47
Reduced
18
Closed
28

Top Buys

Rank Stock Value
1
CPNG icon
Coupang
CPNG
+$8.86M
2
KSU
Kansas City Southern
KSU
+$3.59M
3
CHNG
Change Healthcare Inc. Common Stock
CHNG
+$3.54M
4
PPD
PPD, Inc. Common Stock
PPD
+$3.47M
5
FIVN icon
FIVE9
FIVN
+$3.18M

Top Sells

Rank Stock Value
1
WTW icon
Willis Towers Watson
WTW
+$9.44M
2
MXIM
Maxim Integrated Products
MXIM
+$4.49M
3
ALXN
Alexion Pharmaceuticals
ALXN
+$3.96M
4
WORK
Slack Technologies, Inc.
WORK
+$3.57M
5
SOGO
Sogou Inc. American Depositary Shares, each representing one Class A Ordinary Share
SOGO
+$3.07M

Sector Composition

Rank Sector Weight
1 Healthcare 44.08%
2 Technology 31.3%
3 Consumer Discretionary 7.05%
4 Communication Services 3.66%
5 Industrials 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
EPM icon
76
Evolution Petroleum
EPM
$134M
$148K 0.1%
26,066
+6,266
+32% +$28K
ESTE
77
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
$144K 0.1%
+15,639
New +$144K
VRCA icon
78
Verrica Pharmaceuticals
VRCA
$98.6M
$137K 0.09%
+1,094
New +$123K
IMGN
79
DELISTED
Immunogen Inc
IMGN
$137K 0.09%
24,088
+9,159
+61% +$52.9K
AFMD
80
DELISTED
Affimed
AFMD
$135K 0.09%
2,182
+838
+62% +$55.2K
LXRX icon
81
Lexicon Pharmaceuticals
LXRX
$1.06B
$135K 0.09%
27,978
+11,935
+74% +$49K
TRUE
82
DELISTED
TrueCar
TRUE
$134K 0.09%
32,094
-9,190
-22% -$42.6K
HROW icon
83
Harrow
HROW
$1.47B
$129K 0.09%
14,211
+3,911
+38% +$35.4K
VBIV
84
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$129K 0.09%
1,376
+423
+44% +$40.2K
EVC icon
85
Entravision Communication
EVC
$824M
$126K 0.08%
17,751
-22,574
-56% -$152K
EGY icon
86
Vaalco Energy
EGY
$625M
$122K 0.08%
+41,614
New +$110K
AGEN
87
Agenus
AGEN
$297M
$120K 0.08%
1,167
– –
VSTM icon
88
Verastem
VSTM
$627M
$119K 0.08%
3,224
+839
+35% +$30.8K
SEI
89
Solaris Energy Infrastructure
SEI
$3.85B
$119K 0.08%
+14,247
New +$116K
CNSL
90
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
$110K 0.07%
11,981
-11,758
-50% -$105K
ETON icon
91
Eton Pharmaceutcials
ETON
$1.15B
$109K 0.07%
21,517
+10,884
+102% +$56.6K
PRPH
92
DELISTED
ProPhase Labs
PRPH
$105K 0.07%
+2,026
New +$121K
SYRE icon
93
Spyre Therapeutics
SYRE
$8.97B
$105K 0.07%
+525
New +$91.8K
SURF
94
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$105K 0.07%
+13,932
New +$89.2K
ADMS
95
DELISTED
Adamas Pharmaceuticals
ADMS
$104K 0.07%
21,193
+6,437
+44% +$31.3K
CRDF icon
96
Cardiff Oncology
CRDF
$79.4M
$103K 0.07%
+15,501
New +$97.4K
NAT icon
97
Nordic American Tanker
NAT
$1.31B
$103K 0.07%
40,323
+18,525
+85% +$46.5K
LJPC
98
DELISTED
La Jolla Pharmaceutical Company
LJPC
$102K 0.07%
+25,493
New +$101K
UTI icon
99
Universal Technical Institute
UTI
$1.42B
$100K 0.07%
14,793
– –
WSR
100
DELISTED
Whitestone REIT
WSR
$100K 0.07%
10,300
– –
2 3
4
5 6

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
PPG
Peak Planning Group Centennial, Colorado $361M AUM 22.01% 1-Year Est. Return
PWC
PYA Waltman Capital Knoxville, Tennessee $361M AUM 9.49% 1-Year Est. Return

HighVista Strategies's Q3 2021 Portfolio in Review

As of Q3 2021, HighVista Strategies held 155 positions worth $151M, up 7.2% from $141M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

HighVista Strategies deployed $16.3M of net new capital in Q3 2021, opening 39 new positions and adding to 47 existing holdings. Its largest new stake was Coupang: 256,264 shares worth $7.14M.

By sector, the portfolio is most concentrated in Healthcare at 44% of assets, up from 32% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Alibaba, an estimated $1.39M trimmed.

  • HighVista Strategies's largest Q3 2021 buy was Coupang: 256,264 shares worth $7.14M.
  • HighVista Strategies added most to ESSA Pharma in Q3 2021, an estimated $1.9M increase.
  • HighVista Strategies's biggest Q3 2021 reduction was Alibaba, cutting an estimated $1.39M.
  • HighVista Strategies fully exited Willis Towers Watson in Q3 2021, selling an estimated $9.44M.
  • HighVista Strategies's ten largest holdings make up 49% of its $151M portfolio in Q3 2021.
  • HighVista Strategies opened 39 new positions and closed 28 in Q3 2021.
  • HighVista Strategies's portfolio value rose 7.2% quarter-over-quarter to $151M.

Based on HighVista Strategies's 13F filing for Q3 2021, filed 15 Nov 2021.